Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
Go back to Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications| (NASDAQ: ARQT) | Delayed: 25.38 -1.08 (4.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.46 | 52 Week High | $ | |||
| Open | $26.14 | 52 Week Low | $ | |||
| Day High | $26.75 | P/E | N/A | |||
| Day Low | $25.13 | EPS | $ | |||
| Volume | 19,137,078 | |||||
